Zobrazeno 1 - 10
of 161
pro vyhledávání: '"K. Høgåsen"'
Autor:
P. Hasselqvist, K. Høgåsen, Åge Chr. Thomsen, Anne Kirsti Myrvang Høgåsen, Niels Graudal, Peter Garred, C Homann, Tom Eirik Mollnes
Publikováno v:
Europe PubMed Central
Clusterin and vitronectin are multifunctional regulatory proteins which both serve as complement lysis inhibitors. Previous data have strongly suggested that serum vitronectin is mainly produced in the liver, whereas the biosynthetic origin for serum
Publikováno v:
The American Journal of Pathology. 161:2027-2034
Porcine membranoproliferative glomerulonephritis type II in piglets of the Norwegian Yorkshire breed is considered the first animal model of human dense deposit disease. Porcine dense deposit disease is caused by the absence of the complement regulat
Publikováno v:
Scandinavian Journal of Immunology. 52:483-490
The interaction between a pectin type polysaccharide fraction, PMII, isolated from the leaves of Plantago major, and human complement was tested in two different hemolytic complement-fixation tests and in addition by two ELISA methods detecting compl
Autor:
Torstein Hovig, Lynn A. Spruce, Arvind Sahu, Arnt E. Fiane, K. Høgåsen, Vibeke Videm, Ove J. Mellbye, Tom Eirik Mollnes, John D. Lambris, William T. Moore
Publikováno v:
Xenotransplantation. 6:52-65
Compstatin, a newly described C3-binding peptide, inhibits complement activation by blocking C3 convertase-mediated cleavage of C3. As the complement activation is an essential part of the rejection reaction, we evaluated the ability of Compstatin to
Publikováno v:
Scandinavian Journal of Immunology. 48:312-317
Several complement modulating effects of high-dose intravenous immunoglobulins (IVIG) have been proposed from in vitro studies and experimental animal models. However, the in vivo effects of IVIG on plasma complement in humans are yet not known. We h
Publikováno v:
Kidney International. 53(2):331-349
In situ complement activation in porcine membranoproliferative glomerulonephritis type II. Pigs genetically deficient in complement factor H all develop lethal membranoproliferative glomerulonephritis (MPGN) type II characterized by massive glomerula
Publikováno v:
Mollnes, T E, Andreassen, I H, Hogasen, K, Hack, C E & Harboe, M 1997, ' Effect of whole and fractionated intravenous immunoglobulins on complement in vitro ', Molecular Immunology, vol. 34, pp. 719-729 . https://doi.org/10.1016/S0161-5890(97)00091-6
Molecular Immunology, 34, 719-729. Elsevier Limited
Molecular Immunology, 34, 719-729. Elsevier Limited
Intravenous immunoglobulins (IVIG) are increasingly used for treatment of inflammatory diseases, and the modulation of complement may contribute to some of its beneficial effects. IVIG may bind C1q and activated C3 and C4, and enhance inactivation of
Autor:
Halvor Rollag, Tore G. Abrahamsen, Anne Kirsti Myrvang Høgåsen, Miklos Degré, Mona Holberg-Petersen, K. Høgåsen
Publikováno v:
Archives of Virology. 142:689-698
Complement biosynthesis in monocytes is stimulated by different microorganisms including Gram negative bacteria and yeasts. We have tested the effect of human cytomegalovirus (HCMV) on complement factor 3 (C3) production by cultured human monocytes.
Publikováno v:
APMIS. 105:17-24
Clusterin and the terminal complement pathway synthesized by human umbilical vein endothelial cells are closely linked when detected on co-cultured agarose beads. Clusterin is a multifunctional regulatory protein rendering the terminal complement com
Autor:
Erik Fosse, C. Andersson, Peter Kierulf, K. Høgåsen, Per Venge, Einar Dregelid, Vibeke Brockmeier, Tom Eirik Mollnes, Oddvar Moen
Publikováno v:
The Annals of Thoracic Surgery. 62:1134-1140
Background. Centrifugal pumps are being used increasingly for short-term extracorporeal circulation purposes such as during heart operations. Whether the centrifugal pump improves the cardiopulmonary bypass biocompatibility has not been fully documen